Real-life efficacy and safety of nintedanib in systemic sclerosis-interstitial lung disease: data from an Italian multicentre study.
Campochiaro C, De Luca G, Lazzaroni MG, Armentaro G, Spinella A, Vigone B, Ruaro B, Stanziola A, Benfaremo D, De Lorenzis E, Moccaldi B, Bosello SL, Cuomo G, Beretta L, Zanatta E, Giuggioli D, Del Papa N, Airo P, Confalonieri M, Moroncini G, Dagna L, Matucci-Cerinic M.
Campochiaro C, et al.
RMD Open. 2023 Feb;9(1):e002850. doi: 10.1136/rmdopen-2022-002850.
RMD Open. 2023.
PMID: 36813476
Free PMC article.